Search research articles
Contact Us
Filters
Showing results (51-60 of 148) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Investigation
|
August 5, 2008
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia
Mark Y Chiang, Lanwei Xu, Olga Shestova, et al.
Annals of Surgical Oncology
|
February 8, 2007
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients
Giorgos C Karakousis, Phyllis A Gimotty, Brian J Czerniecki, et al.
Journal of Cutaneous Pathology
|
July 23, 2004
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists
Michael Shapiro, Mary-Margaret Chren, Ross M Levy, et al.
Nature
|
July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells
Andrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Annals of Surgical Oncology
|
November 22, 2013
Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy
Edmund K Bartlett, Meera Gupta, Jashodeep Datta, et al.
Biorxiv : the Preprint Server for Biology
|
December 7, 2021
SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens
Laurent Bartolo, Sumbul Afroz, Yi-Gen Pan, et al.
Journal of the American Academy of Dermatology
|
November 28, 2022
Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis
Cimarron E Sharon, Richard J Straker, Phyllis A Gimotty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma
Phyllis A Gimotty, Patricia Van Belle, David E Elder, et al.
The Journal of Investigative Dermatology
|
June 30, 2016
Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications
Phyllis A Gimotty, Ronald Shore, Nancy L Lozon, et al.
Cancer Biology & Therapy
|
May 28, 2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
Dimitra Sasaroli, Phyllis A Gimotty, Harsh B Pathak, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 148) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Investigation
|
August 5, 2008
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia
Mark Y Chiang, Lanwei Xu, Olga Shestova, et al.
Annals of Surgical Oncology
|
February 8, 2007
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients
Giorgos C Karakousis, Phyllis A Gimotty, Brian J Czerniecki, et al.
Journal of Cutaneous Pathology
|
July 23, 2004
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists
Michael Shapiro, Mary-Margaret Chren, Ross M Levy, et al.
Nature
|
July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells
Andrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Annals of Surgical Oncology
|
November 22, 2013
Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy
Edmund K Bartlett, Meera Gupta, Jashodeep Datta, et al.
Biorxiv : the Preprint Server for Biology
|
December 7, 2021
SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens
Laurent Bartolo, Sumbul Afroz, Yi-Gen Pan, et al.
Journal of the American Academy of Dermatology
|
November 28, 2022
Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis
Cimarron E Sharon, Richard J Straker, Phyllis A Gimotty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma
Phyllis A Gimotty, Patricia Van Belle, David E Elder, et al.
The Journal of Investigative Dermatology
|
June 30, 2016
Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications
Phyllis A Gimotty, Ronald Shore, Nancy L Lozon, et al.
Cancer Biology & Therapy
|
May 28, 2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
Dimitra Sasaroli, Phyllis A Gimotty, Harsh B Pathak, et al.
Page
of 15